Article Information
- Received August 17, 2011
- Revision received March 23, 2012
- Accepted March 29, 2012
- First published May 23, 2012.
- Version of record published May 23, 2012.
Author Information
- Dara G. Ghahremani1,
- Buyean Lee1,
- Chelsea L. Robertson2,
- Golnaz Tabibnia3,
- Andrew T. Morgan1,
- Natalie De Shetler1,
- Amira K. Brown1,
- John R. Monterosso4,
- Adam R. Aron5,
- Mark A. Mandelkern6,
- Russell A. Poldrack7, and
- Edythe D. London1,2,8
- 1Departments of Psychiatry and Biobehavioral Sciences and
- 2Molecular and Medical Pharmacology, and
- 8Brain Research Institute, University of California, Los Angeles, Los Angeles, California 90095,
- 3Department of Social and Decision Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania 15212,
- 4Department of Psychology, University of Southern California, Los Angeles, California 90089,
- 5Department of Psychology, University of California, San Diego, La Jolla, California 92093,
- 6Department of Physics, University of California, Irvine, Irvine, California 92697, and
- 7Departments of Psychology and Neurobiology, University of Texas, Austin, Texas 78712
Author contributions
Author contributions: D.G.G., B.L., G.T., J.R.M., A.R.A., R.A.P., and E.D.L. designed research; D.G.G., B.L., C.L.R., G.T., A.T.M., N.D.S., A.K.B., J.R.M., M.A.M., and E.D.L. performed research; D.G.G., B.L., C.L.R., and A.T.M. analyzed data; D.G.G., A.R.A., R.A.P., and E.D.L. wrote the paper.
Disclosures
- Received August 17, 2011.
- Revision received March 23, 2012.
- Accepted March 29, 2012.
This work was supported by National Institutes of Health (NIH) Grants P20 DA022539 and R01 DA020726 (E.D.L.), the Consortium for Neuropsychiatric Phenomics NIH Roadmap for Medical Research Grants UL1 DE019580 and RL1 DA024853 (E.D.L.), and University of California at Los Angeles General Clinical Research Center Grant M01 RR00865. Additional funding was provided by endowments from the Thomas P. and Katherine K. Pike Chair in Addiction Studies and the Marjorie M. Greene Trust.
The authors declare no competing financial interests.
- Correspondence should be addressed to either Dr. Dara Ghahremani or Dr. Edythe London, UCLA Semel Institute, 740 Westwood Plaza, C8-831, Los Angeles, CA 90095. darag{at}ucla.edu or elondon{at}mednet.ucla.edu
Online Impact